The United Laboratories International Holdings's market cap is currently ―. The company's EPS TTM is $0.209; its P/E ratio is 5.91; and it has a dividend yield of 3.60%. The United Laboratories International Holdings is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Jun 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 4.04B	¥ 3.33B	¥ 3.62B	¥ 3.00B	¥ 3.08B
Total Assets	¥ 17.35B	¥ 16.33B	¥ 15.85B	¥ 14.96B	¥ 15.13B
Total Debt	¥ 2.15B	¥ 1.84B	¥ 2.25B	¥ 2.21B	¥ 3.26B
Net Debt	¥ -1.89B	¥ -1.49B	¥ -1.37B	¥ -785.47M	¥ 187.94M
Total Liabilities	¥ 7.61B	¥ 6.99B	¥ 6.76B	¥ 6.35B	¥ 7.29B
Stockholders Equity	¥ 9.75B	¥ 9.34B	¥ 9.09B	¥ 8.61B	¥ 7.84B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in CNY

The United Laboratories International Holdings Earnings and Revenue History

Income Statement >

The United Laboratories International Holdings Debt to Assets

Balance Sheet >

The United Laboratories International Holdings Cash Flow

Cash Flow >

The United Laboratories International Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing